<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Infection Immunity and Inflammation</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E3595DA0-9A9D-41C5-84B3-C2FA3FBB0F23"><gtr:id>E3595DA0-9A9D-41C5-84B3-C2FA3FBB0F23</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Moody</gtr:surname><gtr:orcidId>0000-0003-1762-9238</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E3FF04F3-296B-4065-AC0D-AEC75CA301D9"><gtr:id>E3FF04F3-296B-4065-AC0D-AEC75CA301D9</gtr:id><gtr:firstName>Wilhelm</gtr:firstName><gtr:surname>Schwaeble</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/380C75EB-5798-45D1-8DF6-522F675834C8"><gtr:id>380C75EB-5798-45D1-8DF6-522F675834C8</gtr:id><gtr:firstName>Russell</gtr:firstName><gtr:surname>Wallis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000191"><gtr:id>026677B9-5B3B-49BA-8BEB-A6374E9AE1B7</gtr:id><gtr:title>Molecular analysis of complement activation via the classical pathway</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000191</gtr:grantReference><gtr:abstractText>The human immune system uses two main weapons to counter invading pathogens: adaptive immunity, which includes the production of antibodies that develop over time to target invading bacteria; and innate immunity, which is ever present and recognizes conserved parts of bacteria, such as their cell walls. The complement cascade provides a bridge between innate and adaptive immunity: it destroys bacteria directly via innate processes and helps to direct and stimulate an effective adaptive response. Because of its central role, complement dysfunction is associated with a range of human diseases, including severe bacterial infections, kidney disease and autoimmune diseases such as lupus and rheumatoid arthritis. One of the main pathways of complement activation is known as the classical pathway, in which complement proteins bind to bacteria and set off a chain of reactions directed at killing them. In this grant proposal, we aim to develop a thorough understanding this pathway by studying the way in which the components interact with each other to initiate the reaction cascade. We have already established methods for producing key elements using recombinant DNA technology so that their mode of action can be investigated in a systematic way. As well as providing novel information that will help us to understand how complement works, this project will also foster the development of novel reagents which can be used to change complement activity. For example, inhibitors of complement could be used to prevent tissue damage in conditions where complement activates at the wrong time or place. Similarly, modified components can be used to bind and neutralize specific targets such as antibiotic resistant bacteria or diseased cells.</gtr:abstractText><gtr:technicalSummary>The classical pathway of complement activation provides a frontline defence against invading pathogens. It is a central effector of natural protection, one of two current research priorities of the MRC. It neutralises invading cells directly via antibody-dependent and -independent mechanism and elicits a range of cellular responses designed to protect the host and eliminate foreign material, including inflammation, phagocytosis and stimulation of an effective adaptive immune response. Despite its important roles, the mechanisms underlying the activation and regulation of this branch of the immune system are relatively poorly understood. The goal of the proposed work is to understand how molecular interactions control complement activation via C1, the initiating complex of the classical pathway. Biochemical and structural approaches are specifically designed to identify detailed binding and structural information. The results of this study are expected to be of significance to both basic and applied applications. Understanding the fundamental issues of recognition in complement activation has general practical applications in protein-protein interactions and protein engineering and lays the foundations for the development of therapeutic agents designed to prevent complement-mediated host damage for use in the treatment of inflammatory diseases, such as rheumatoid arthritis and in ischemia-reperfusion disorders. As part of this project, short constrained peptide mimics will be developed, synthesized and characterized. These will serve as specific inhibitors of C1q-C1rs interactions, providing a novel set of reagents to dissect the complex biological processes that these proteins mediate. We also plan to use our knowledge of complement interactions to engineer novel specificities into the framework of C1qs, MBLs and ficolins, thereby altering target specificity whilst retaining the ability to activate complement and stimulate the host?s immune system. By targeting bacterial cells and endogenous epitopes associated with disease, these immunologically active reagents will offer a novel approach to tackle disease.</gtr:technicalSummary><gtr:fund><gtr:end>2014-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>438794</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Structural Molecular Biology</gtr:department><gtr:description>Structure function analysis of MBL-MASP interaction</gtr:description><gtr:id>BCCAAA9D-EB60-49E0-88AC-5DD46482D438</gtr:id><gtr:impact>Paper in Journal of Biological Chemistry 22167201</gtr:impact><gtr:outcomeId>K4tEaajXi1Q-1</gtr:outcomeId><gtr:partnerContribution>SAXS of MBL-MASP complexes</gtr:partnerContribution><gtr:piContribution>Production of MBL./MASPs for structural analysis by SAXS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Randall Division of Cell &amp; Molecular Biophysics</gtr:department><gtr:description>Structure function analysis of C1q-IgM interactions</gtr:description><gtr:id>9B4B80C3-7970-411B-B8DE-D14DB15AD988</gtr:id><gtr:impact>Currently in preliminary stages of research</gtr:impact><gtr:outcomeId>dTkyfNT1D8N-1</gtr:outcomeId><gtr:partnerContribution>characterising the interaction of IgM with C1q</gtr:partnerContribution><gtr:piContribution>Production of recombinant C1q for structure function analysis with IgM</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Work experience for college/sixth form students</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>855B515F-3287-45C6-899C-3A6DA35DDC44</gtr:id><gtr:impact>We hosted two work experience students from a local 6th form college. We explained our research and they gained experience of working in a lab, including setting up basic experiments e.g. PCR reactions

The college are keen to continue this arrangement in the future so that students can experience working in a research laboratory. We plan to host at least two 6th form students each year.</gtr:impact><gtr:outcomeId>Jiv7bid92bS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience for School students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5F5B53B8-5ECF-41D1-AB00-AD442D710C15</gtr:id><gtr:impact>We hosted two students from local schools for 1 week (each year) as work experience.

Science students from a nearby school were shown how research is carried out in the University and were able to help set up and perform experiments (e.g. running gels and PCR experiments) under supervision of Researchers in the laboratory.</gtr:impact><gtr:outcomeId>HkpcVAGpxFc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Randall Institiute KCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EFA4B9CB-1D9D-4BE5-88D8-570FA879833A</gtr:id><gtr:impact>Seminar at the Randall Insstitute KCL, London for postgraduates and academics

Collaboration with Brian Sutton (KCL) on C1q-IgM interactions</gtr:impact><gtr:outcomeId>iUXbRQg1PqD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patterson Institute for Cancer Research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CF8106B1-8590-4FE2-8B64-877FFA2B98F1</gtr:id><gtr:impact>40 academics attended day session of talks/seminars. I presented our recent work on the structure of the C1 complex of complement activation

N/A</gtr:impact><gtr:outcomeId>pPEHsek4oXo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>478A6B2A-67D2-4BC4-AE32-C27CF51A804B</gtr:id><gtr:impact>Seminar at the Institute of Structural and Molecular Biology UCL to post graduate students and academics

Collaboration with Steve Perkins on MBL-MASP structure/function</gtr:impact><gtr:outcomeId>kctV32z9Qqx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>532558</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K011715/1</gtr:fundingRef><gtr:id>50716773-FA6C-43E0-94C9-B97DC0EBCD72</gtr:id><gtr:outcomeId>pB1HPUyu9ns</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have made a recombinant form (produced in E. coli) of the globular heads of complement component C1q. This fragment is normally composed of three separate polypeptide chains and according to our knowledge has never be produced before. It will enable us to perform structure/function analysis of C1q interactions</gtr:description><gtr:id>4D9E975A-585A-4BAC-854E-04FEA307F4C1</gtr:id><gtr:impact>Ongoing research</gtr:impact><gtr:outcomeId>ZxDAHjXsrUu</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>recombinant C1q heads</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>734152EB-BC2D-4E5A-8E2D-13F9F31D79A6</gtr:id><gtr:title>Near-planar solution structures of mannose-binding lectin oligomers provide insight on activation of lectin pathway of complement.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85627c6740fc4161499910b00f7a76e7"><gtr:id>85627c6740fc4161499910b00f7a76e7</gtr:id><gtr:otherNames>Miller A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14784_24_22167201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69BBDC4D-DD26-4DD3-BEA7-51968193B8E4</gtr:id><gtr:title>Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81e05113304b82f1e64e218eba6b287b"><gtr:id>81e05113304b82f1e64e218eba6b287b</gtr:id><gtr:otherNames>Venkatraman Girija U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14784_24_23922389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>164618B1-D875-45F0-BA7B-1DCF06F9A672</gtr:id><gtr:title>Surface properties: Immune attack on nanoparticles.</gtr:title><gtr:parentPublicationTitle>Nature nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce19e5acd9833452a471e3210c802621"><gtr:id>ce19e5acd9833452a471e3210c802621</gtr:id><gtr:otherNames>Sim RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1748-3387</gtr:issn><gtr:outcomeId>pm_14784_24_21293484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20004C54-DB29-4CCB-A476-22F64DB8DCB1</gtr:id><gtr:title>Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6856aa066a730da9d045725584a65ea"><gtr:id>c6856aa066a730da9d045725584a65ea</gtr:id><gtr:otherNames>Schwaeble WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14784_24_21502512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>160FD403-F0D3-4C0F-AD56-8FB94AFC7D2A</gtr:id><gtr:title>Structure of the C1r-C1s interaction of the C1 complex of complement activation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bfb11a71029bc4878e1c5dd95ea5ac"><gtr:id>74bfb11a71029bc4878e1c5dd95ea5ac</gtr:id><gtr:otherNames>Almitairi JOM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5aa7d65b6acbf1.88486971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81C12468-F67F-4671-8D0A-C1A8887F5FB7</gtr:id><gtr:title>The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9081f25d18b277881885a2abf2760afb"><gtr:id>9081f25d18b277881885a2abf2760afb</gtr:id><gtr:otherNames>Ali YM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14784_24_22792067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F21727F1-F43C-4969-9617-34E4CEBDA598</gtr:id><gtr:title>Sequence-controlled multi-block glycopolymers to inhibit DC-SIGN-gp120 binding.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/249808295c23f4d85591d33c08cc2225"><gtr:id>249808295c23f4d85591d33c08cc2225</gtr:id><gtr:otherNames>Zhang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>pm_14784_24_23494988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66174C23-490F-4C17-9DF7-26D0784FB6C7</gtr:id><gtr:title>Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15e2c8f1d7895a11784c64fdc6185bbf"><gtr:id>15e2c8f1d7895a11784c64fdc6185bbf</gtr:id><gtr:otherNames>Saeed A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>pm_14784_24_23841802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A2CF813-3A33-4A53-A26F-FF28F0D91194</gtr:id><gtr:title>A molecular dynamics study of C1r and C1s dimers: implications for the structure of the C1 complex.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8aaad9e0477ed9f32da3728efe8f13d6"><gtr:id>8aaad9e0477ed9f32da3728efe8f13d6</gtr:id><gtr:otherNames>Beveridge AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn><gtr:outcomeId>pm_14784_24_22488778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DE00E72-5213-4F7A-B5EC-181412E0F2F3</gtr:id><gtr:title>Macromol. Rapid Commun. 19/2013</gtr:title><gtr:parentPublicationTitle>Macromolecular Rapid Communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/887d8d0668071124a9629e98422c5b0c"><gtr:id>887d8d0668071124a9629e98422c5b0c</gtr:id><gtr:otherNames>Huang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_14784_24_24092557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A030DC8-45C9-4D7D-9953-2F7FC313585F</gtr:id><gtr:title>Opsonizing properties of rat ficolin-A in the defence against Cryptococcus neoformans.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2ad1c5550012bc220f27087901807ba"><gtr:id>f2ad1c5550012bc220f27087901807ba</gtr:id><gtr:otherNames>Schelenz S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>pm_14784_24_22789560</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1EC3D3E-88F9-4F36-91DE-17AF9A455365</gtr:id><gtr:title>Synthetic glycopolypeptides as potential inhibitory agents for dendritic cells and HIV-1 trafficking.</gtr:title><gtr:parentPublicationTitle>Macromolecular rapid communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/887d8d0668071124a9629e98422c5b0c"><gtr:id>887d8d0668071124a9629e98422c5b0c</gtr:id><gtr:otherNames>Huang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1022-1336</gtr:issn><gtr:outcomeId>pm_14784_24_24038760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F2C65F5-C765-4754-91EA-41A6F8383402</gtr:id><gtr:title>Dendritic cell lectin-targeting sentinel-like unimolecular glycoconjugates to release an anti-HIV drug.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/249808295c23f4d85591d33c08cc2225"><gtr:id>249808295c23f4d85591d33c08cc2225</gtr:id><gtr:otherNames>Zhang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>545b648a1f1ff3.57748212</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000191</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>